- Asthenic syndrome in pregnant women as a manifestation of the long-term effects of previous cranio-cerebral injury: treatment characteristics
Asthenic syndrome in pregnant women as a manifestation of the long-term effects of previous cranio-cerebral injury: treatment characteristics
PERINATOLOGY AND PEDIATRIC. UKRAINE. 2018.3(75):35-39; doi 10.15574/PP.2018.75.35
Limanskaya А. Yu., Naumchyk A. M., Ogorodnyk A. O., Davydova Iu. V.
SI Institute of Pediatrics, Obstetrics and Gynecology named after academician O. Lukyanova of the National Academy of Medical Sciences of Ukraine, Kyiv
Objective: to improve the general condition and life quality of pregnant women with cranio-cerebral injury (CCI) in the past medical history.
Materials and methods. There were 18 women with 25–35 gestation weeks who had a history of CCI, with clinical symptoms of asthenic syndrome and cognitive impairment (as a manifestation of long-term effects of CCI) during the current pregnancy. All pregnant women on the recommendation of a neurologist were administered the drug citicoline. The psychoemotional state and life quality indicators were examined using special questionnaires before and after the treatment.
Results and conclusions. Treatment of pregnant women with long-term consequences of CCI requires a comprehensive approach, since such women have significant psych-_emotional and cognitive disorders that are caused by organic brain pathology and potentiated by the presence of pregnancy. The therapy with citicoline helps reducing the severity of cognitive impairment, improves well-being and performance capability.
Key words: cranio-cerebral injury, pregnancy, asthenic syndrome, quality of life.
1. Аlvarez_Sabin J, Roman GС. (2011). Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke. 42:40—43.
2. Bramlett HM, Dalton DW. (2004, Feb. 1). Pathophysiology of Cerebral Ischemia and Brain Trauma: Similarities and Differences. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1097/01.WCB.0000111614.19196.04
3. Cotroneo AM, Castagna A, Putignano P et al. (2013). Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clin Interv Aging.8:131—7.
4. Davalos A et al. (2012). Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo_controlled study (ICTUS trial). Lancet.380:349—57.
5. Davalos A, Secades J. (2011). Citicoline preclinical and clinical update 2009—2010. Stroke. 42:36—9.
6. Grieb P. (2014). Neuroprotective properties of citicoline: facts, doubts and unresolved issues. CNS Drugs. 28;3:185—193.
7. Guidelines for the Management of a Pregnant Trauma Patient (2015). J Obstet Gynaecol Can. 37(6):553—571.
8. Krupinski J, Abudawood M, Matou-Nasri S et al. (2012). Citicoline induces angiogenesis improving survival of vascular/human brain microvessel endothelial cells through pathways involving ERK1/2 and insulin receptor substrate-1. Vasc. Cell. 4. 20. https://doi.org/10.1186/2045-824X-4-20.
9. Qureshi I, Endres JR. (2010). Citicoline: a novel therapeutic agent with neuroprotective, neuromodulatory, and neuroregenerative properties. Natural Medicine Journal. 2; 6:11—25.
10. Saver JL. (2008). Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. Rev Neurol Dis. 5;4:167—177.
11. Secades JJ. (2012). Probably role of citicoline in stroke rehabilitation: review of the literature. Rev. Neurol. 54; 3: 173—179.
12. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
13. Spielberger CD. (1989). State-Trait Anxiety Inventory: Bibliography. 2nd ed. Palo Alto, CA: Consulting Psychologists Press.
14. Vulkov I, Bozhinov P (2016). Head injury during pregnancy. Akush Ginekol (Sofiia).55(2).
Article received: Jun 18, 2018. Accepted for publication: Aug 11, 2018.